Allogene Therapeutics
ALLO
ALLO
179 hedge funds and large institutions have $835M invested in Allogene Therapeutics in 2022 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 72 increasing their positions, 45 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
179
Holders Change
+2
Holders Change %
+1.13%
% of All Funds
2.83%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
32
Increased
72
Reduced
45
Closed
30
Calls
$1.24M
Puts
$764K
Net Calls
+$472K
Net Calls Change
+$201K
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$71.8M |
| 2 |
2
Goldman Sachs
New York
|
$27M |
| 3 |
3
T. Rowe Price Associates
Baltimore,
Maryland
|
$38.9M |
| 4 |
4
Renaissance Technologies
New York
|
$8.88M |
| 5 |
5
Two Sigma Investments
New York
|
$8.69M |
